Literature DB >> 17109511

Occult hepatitis C virus infection: a new form of hepatitis C.

Vicente Carreño1.   

Abstract

Occult hepatitis C virus (HCV) infection is a new recently characterized entity. This occult infection can be present in two different clinical situations: in anti-HCV negative, serum HCV-RNA negative patients with abnormal liver function tests and in anti-HCV positive subjects with normal values of liver enzymes and without serum HCV-RNA. This review describes recent studies of occult HCV infection in both kinds of patients.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17109511      PMCID： PMC4087333          DOI： 10.3748/wjg.v12.i43.2000

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  23 in total

1.  Abnormal liver tests with unexplained cause in patients with hepatitis C virus infection.

Authors:  Walter J Coyle
Journal:  Curr Gastroenterol Rep       Date:  2004-08

2.  Seronegative hepatitis C virus infection, not just RNA detection.

Authors:  Jack T Stapleton; Warren N Schmidt; Louis Katz
Journal:  J Infect Dis       Date:  2004-08-01       Impact factor: 5.226

3.  Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology.

Authors:  W N Schmidt; J T Stapleton; D R LaBrecque; F A Mitros; P A Kirby; M J Phillips; D L Brashear
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

4.  Surreptitious hepatitis C virus (HCV) infection detected in the majority of patients with cryptogenic chronic hepatitis and negative HCV antibody tests.

Authors:  W N Schmidt; P Wu; J Cederna; F A Mitros; D R LaBrecque; J T Stapleton
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

5.  Comparative study between occult hepatitis C virus infection and chronic hepatitis C.

Authors:  M Pardo; J M López-Alcorocho; E Rodríguez-Iñigo; I Castillo; V Carreño
Journal:  J Viral Hepat       Date:  2007-01       Impact factor: 3.728

6.  Cryptogenic chronic liver disease and serum or liver hepatitis B virus markers. Their possible correlations and etiologic significance.

Authors:  G Diodati; P Pontisso; P Bonetti; D Stenico; F Noventa; A Alberti; G Realdi
Journal:  Digestion       Date:  1988       Impact factor: 3.216

7.  Hepatitis C virus replicates in peripheral blood mononuclear cells of patients with occult hepatitis C virus infection.

Authors:  I Castillo; E Rodríguez-Iñigo; J Bartolomé; S de Lucas; N Ortíz-Movilla; J M López-Alcorocho; M Pardo; V Carreño
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

8.  Hepatitis C virus replicates in the liver of patients who have a sustained response to antiviral treatment.

Authors:  Inmaculada Castillo; Elena Rodríguez-Iñigo; Juan Manuel López-Alcorocho; Margarita Pardo; Javier Bartolomé; Vicente Carreño
Journal:  Clin Infect Dis       Date:  2006-10-05       Impact factor: 9.079

9.  Detection of hepatitis C virus (HCV) RNA in the liver of healthy, anti-HCV antibody-positive, serum HCV RNA-negative patients with normal alanine aminotransferase levels.

Authors:  Vicente Carreño; Margarita Pardo; Juan Manuel López-Alcorocho; Elena Rodríguez-Iñigo; Javier Bartolomé; Inmaculada Castillo
Journal:  J Infect Dis       Date:  2006-05-16       Impact factor: 5.226

10.  Hepatitis C virus persistence after spontaneous or treatment-induced resolution of hepatitis C.

Authors:  Tram N Q Pham; Sonya A MacParland; Patricia M Mulrooney; Helen Cooksley; Nikolai V Naoumov; Tomasz I Michalak
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103
View more
  20 in total

1.  Long-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirin.

Authors:  María Trapero-Marugán; Jorge Mendoza; María Chaparro; Leticia González-Moreno; José Andrés Moreno-Monteagudo; María Jesús Borque; Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2011-01-28       Impact factor: 5.742

2.  Vertical transmission of the hepatitis C virus: Current knowledge and issues.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

3.  Hepatitis B and hepatitis C viral infections in patients with chronic lymphocytic leukemia.

Authors:  Gerald Y Minuk; Betty Lerner; Spencer B Gibson; James B Johnston; Julia Uhanova; Anton Andonov; Jun Wu
Journal:  Can J Gastroenterol Hepatol       Date:  2014-03

4.  Prevalence of occult hepatitis C virus among hemodialysis patients in Tanta university hospitals: a single-center study.

Authors:  Ghada Abdelmoemen; Samy Abdelkader Khodeir; Sabry Abou-Saif; Abdelrahman Kobtan; Sherief Abd-Elsalam
Journal:  Environ Sci Pollut Res Int       Date:  2017-12-06       Impact factor: 4.223

5.  Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection.

Authors:  F Nesrine; H Saleh
Journal:  Afr Health Sci       Date:  2012-03       Impact factor: 0.927

6.  Desperately seeking hepatitis C virus.

Authors:  Ricardo Moreno-Otero
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

7.  Occult persistence and lymphotropism of hepatitis C virus infection.

Authors:  Tram-Nq Pham; Tomasz-I Michalak
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

8.  Occult hepatitis C virus infection revisited with ultrasensitive real-time PCR assay.

Authors:  Philippe Halfon; Marc Bourlière; Denis Ouzan; Damien Sène; David Saadoun; Hacène Khiri; Guillaume Pénaranda; Agnes Martineau; Valérie Oulès; Patrice Cacoub
Journal:  J Clin Microbiol       Date:  2008-04-30       Impact factor: 5.948

9.  Occult HCV infection: an unexpected finding in a population unselected for hepatic disease.

Authors:  Laura De Marco; Anna Gillio-Tos; Valentina Fiano; Guglielmo Ronco; Vittorio Krogh; Domenico Palli; Salvatore Panico; Rosario Tumino; Paolo Vineis; Franco Merletti; Lorenzo Richiardi; Carlotta Sacerdote
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

10.  Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection.

Authors:  Matthew Hoare; William T H Gelson; Simon M Rushbrook; Martin D Curran; Tracy Woodall; Nicholas Coleman; Susan E Davies; Graeme J M Alexander
Journal:  Hepatology       Date:  2008-12       Impact factor: 17.425
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.